![Michael Lutz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Lutz
Amministratore Delegato presso
Iota Sciences Ltd.
Profilo
Michael Lutz currently works at Iota Sciences Ltd., as Chief Executive Officer & Director from 2023, 2cureX ApS, as Director from 2020, and Noscendo GmbH, as Director.
Dr. Lutz also formerly worked at HepaRegeniX GmbH, as Chief Executive Officer & Managing Director, NTP Nano Tech Projects SRL, as Executive Chairman, Lophius Biosciences GmbH, as Managing Director, and 2cureX AB, as Independent Director from 2020 to 2023.
Dr. Lutz received his doctorate degree from Swiss Federal Institute of Technology.
Posizioni attive di Michael Lutz
| Società | Posizione | Inizio |
|---|---|---|
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Direttore/Membro del Consiglio | 01/01/2020 |
Noscendo GmbH
 Noscendo GmbH Medical SpecialtiesHealth Technology Develops bioinformatics solutions for identifying and assess pathogens in bloodstream associated & related infections | Direttore/Membro del Consiglio | - |
Iota Sciences Ltd.
 Iota Sciences Ltd. Packaged SoftwareTechnology Services Develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research | Amministratore Delegato | 01/12/2022 |
Precedenti posizioni note di Michael Lutz
| Società | Posizione | Fine |
|---|---|---|
| 2CUREX AB | Direttore/Membro del Consiglio | 01/02/2023 |
NTP Nano Tech Projects SRL
 NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services Develops advanced optical-laser microscopy technologies and devices | Presidente | - |
HepaRegeniX GmbH
 HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases | Amministratore Delegato | - |
Lophius Biosciences GmbH
 Lophius Biosciences GmbH BiotechnologyHealth Technology Develops t-cell-based diagnostic tests and provides novel solutions for infectious diseases | Amministratore Delegato | - |
Formazione di Michael Lutz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
7
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
Lophius Biosciences GmbH
Lophius Biosciences GmbH BiotechnologyHealth Technology Develops t-cell-based diagnostic tests and provides novel solutions for infectious diseases | Health Technology |
HepaRegeniX GmbH
HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases | Health Technology |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research | Technology Services |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services Develops advanced optical-laser microscopy technologies and devices | Commercial Services |
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
Noscendo GmbH
Noscendo GmbH Medical SpecialtiesHealth Technology Develops bioinformatics solutions for identifying and assess pathogens in bloodstream associated & related infections | Health Technology |
